Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration
- Resource Type
- Article
- Source
- In
Clinical Lymphoma Myeloma and Leukemia February 2014 14(1):73-79 - Subject
- Language
- ISSN
- 2152-2650